Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Treasury Shares: 2012-2024

Historic Treasury Shares for Agios Pharmaceuticals (AGIO) over the last 11 years, with Dec 2024 value amounting to $16.2 million.

  • Agios Pharmaceuticals' Treasury Shares changed negligibly% to $802.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $802.5 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $802.5 million for FY2024, which is negligibly% changed negligibly from last year.
  • Agios Pharmaceuticals' Treasury Shares amounted to $802.5 million in FY2024, which was down 0.00% from $802.5 million recorded in FY2023.
  • Agios Pharmaceuticals' Treasury Shares' 5-year high stood at $802.5 million during FY2021, with a 5-year trough of $802.5 million in FY2021.
  • Its 3-year average for Treasury Shares is $5.4 billion, with a median of $16.2 million in 2024.
  • In the last 5 years, Agios Pharmaceuticals' Treasury Shares spiked by 99,900.00% in 2023 and then tumbled by 99.90% in 2024.
  • Agios Pharmaceuticals' Treasury Shares (Yearly) stood at $16.2 million in 2021, then remained steady at $16.2 million in 2022, then surged by 99,900.00% to $16.2 billion in 2023, then plummeted by 99.90% to $16.2 million in 2024.